Global Search

Search articles, concepts, and chapters

Parravano Mariacristina

8 articles in GJC

8 articles in GJC

3.

Macular versus Retinal Nerve Fiber Layer Parameters for Diagnosing Manifest Glaucoma: A Systematic Review of Diagnostic Accuracy Studies.

Oddone Francesco, Lucenteforte Ersilia, Michelessi Manuele, Rizzo Stanislao, Donati Simone, Parravano Mariacristina et al.

OphthalmologyFeb 2016115 citationsSystematic Review

This review found retinal nerve fiber layer (RNFL) parameters remain slightly better than macular parameters for diagnosing manifest glaucoma with OCT, but differences are small, guiding current diagnostic choices.

4.

Influence of disc size on optic nerve head versus retinal nerve fiber layer assessment for diagnosing glaucoma.

Oddone Francesco, Centofanti Marco, Tanga Lucia, Parravano Mariacristina, Michelessi Manuele, Schiavone Mauro et al.

OphthalmologyJul 201137 citationsCross-Sectional Study

This study found optic disc size significantly impacts HRT3 glaucoma diagnosis, but not OCT or GDx RNFL assessments, suggesting OCT/GDx provide more consistent diagnostic accuracy across varying disc sizes.

5.

Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine.

Tanga Lucia, Centofanti Marco, Oddone Francesco, Parravano Mariacristina, Parisi Vincenzo, Ziccardi Lucia et al.

Graefes Arch Clin Exp OphthalmolMay 20118 citationsCase-Control Study

This study found hydroxychloroquine patients without toxicity signs had significantly reduced retinal function via frequency-doubling perimetry, suggesting its utility for early detection of drug-induced retinal damage.

6.

Interleukin-1beta tear concentration in glaucomatous and ocular hypertensive patients treated with preservative-free nonselective beta-blockers.

Manni Gianluca, Centofanti Marco, Oddone Francesco, Parravano Mariacristina, Bucci Massimo G

Am J OphthalmolJan 200543 citationsRandomized Controlled Trial

This study found preserved beta-blocker eye drops significantly increase tear inflammatory markers (IL-1beta) and reduce tear film stability in glaucoma patients, suggesting preservative-free options are better for long-term use.

7.

A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients.

Manni Gianluca, Centofanti Marco, Parravano Mariacristina, Oddone Francesco, Bucci Massimo G

Graefes Arch Clin Exp OphthalmolSep 200420 citationsRandomized Controlled Trial

This study found bimatoprost and latanoprost/timolol combination equally lowered IOP in glaucoma patients, but the combination had fewer ocular side effects, guiding treatment choices.

All 8 articles loaded